We partner with pharmaceutical, biotechnology, and medical device companies to validate computerized software systems and strengthen audit-ready quality processes—using risk-based frameworks aligned with GAMP 5 and FDA regulations.
Two connected disciplines under one accountable professional umbrella, providing end-to-end audit confidence.
We design and execute custom validation pathways for the systems your operations rely on—fully compliant with GAMP 5 risk models and 21 CFR Part 11 requirements.
Key Deliverables
From pre-clinical research to manufacturing and active distribution, we help you implement standard quality assurance processes that remain audit-resilient year-round.
Key Deliverables
We deploy and configure the GxP-critical platforms your operations depend on (eQMS, LIMS, ERP, and document management), with validation built in from day one rather than bolted on after go-live.
Key Deliverables
Validation doesn’t end at launch. We keep your GxP systems in a continuous validated state through patches, upgrades, integrations, and organizational change, so you stay inspection-ready year-round.
Key Deliverables
Assess your software configuration and immediately calculate a simulated Readiness Index score, identifying exact documentation missing from your validation file.
Life science and pharma teams often treat validation as a massive, bureaucratic obstacle. We find that companies struggle with three main trends that invite regulatory risk:
Systems were validated at launch, but months of software patches, system integrations, and configurations have happened with zero updates to the Validation Plan.
Wasting hundreds of engineering hours compiling massive stacks of printed screenshots and manual signatures without applying modern risk-weighted CSA methodology.
Failing to lock system database backend access or leaving audit trail functions disabled—leading to direct observations from FDA auditors.
We evaluate your operational systems against strict GAMP 5 models, finding data leakage points, Part 11 software flaws, and out-of-sync configuration files.
Instead of standard cookie-cutter testing, we plan a custom Validation Master Plan that allocates deep verification testing only to high GxP-impact software processes.
We draft and execute the IQ, OQ, and PQ validation scripts alongside your team, ensuring clean signatures and ironclad evidence captures (e.g. database captures, error logs).
We package complete Traceability Matrices, release summary documents, and train your staff, so you are fully prepared for FDA audits and reviews.
Snehdeep Digital Transformation is an ISO 9001:2015 certified partner for Life Science and Pharma companies. We operate alongside your internal Quality, Validation, and IT teams to engineer audit-ready validation frameworks and processes. We believe that validation shouldn’t be an afterthought or a burden—it should be a structured, seamless pathway to deployment.
Protocols pre-configured for rigorous FDA, EMA, and MHRA audit inspections.
We apply true GAMP Category 4 and 5 scaling to cut testing hours in half.
FDA is enforcing custom risk-focused validation. Moving away from standard paper checklists towards risk-weighted critical testing.
Recent Annex 11 amendments mandate robust governance for Cloud platforms, secure AI integrations, and rigorous data traceability metrics.